Literature DB >> 22302785

Hyperphosphorylation of the cardiac ryanodine receptor at serine 2808 is not involved in cardiac dysfunction after myocardial infarction.

Hongyu Zhang1, Catherine A Makarewich, Hajime Kubo, Wei Wang, Jason M Duran, Ying Li, Remus M Berretta, Walter J Koch, Xiongwen Chen, Erhe Gao, Héctor H Valdivia, Steven R Houser.   

Abstract

RATIONALE: Abnormal behavior of the cardiac ryanodine receptor (RyR2) has been linked to cardiac arrhythmias and heart failure (HF) after myocardial infarction (MI). It has been proposed that protein kinase A (PKA) hyperphosphorylation of the RyR2 at a single residue, Ser-2808, is a critical mediator of RyR dysfunction, depressed cardiac performance, and HF after MI.
OBJECTIVE: We used a mouse model (RyRS2808A) in which PKA hyperphosphorylation of the RyR2 at Ser-2808 is prevented to determine whether loss of PKA phosphorylation at this site averts post MI cardiac pump dysfunction. METHODS AND
RESULTS: MI was induced in wild-type (WT) and S2808A mice. Myocyte and cardiac function were compared in WT and S2808A animals before and after MI. The effects of the PKA activator Isoproterenol (Iso) on L-type Ca(2+) current (I(CaL)), contractions, and [Ca(2+)](I) transients were also measured. Both WT and S2808A mice had depressed pump function after MI, and there were no differences between groups. MI size was also identical in both groups. L type Ca(2+) current, contractions, Ca(2+) transients, and SR Ca(2+) load were also not significantly different in WT versus S2808A myocytes either before or after MI. Iso effects on Ca(2+) current, contraction, Ca(2+) transients, and SR Ca(2+) load were identical in WT and S2808A myocytes before and after MI at both low and high concentrations.
CONCLUSIONS: These results strongly support the idea that PKA phosphorylation of RyR-S2808 is irrelevant to the development of cardiac dysfunction after MI, at least in the mice used in this study.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22302785      PMCID: PMC3322671          DOI: 10.1161/CIRCRESAHA.111.255158

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  46 in total

1.  PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.

Authors:  S O Marx; S Reiken; Y Hisamatsu; T Jayaraman; D Burkhoff; N Rosemblit; A R Marks
Journal:  Cell       Date:  2000-05-12       Impact factor: 41.582

2.  Functional adult myocardium in the absence of Na+-Ca2+ exchange: cardiac-specific knockout of NCX1.

Authors:  Scott A Henderson; Joshua I Goldhaber; Jessica M So; Tieyan Han; Christi Motter; An Ngo; Chana Chantawansri; Matthew R Ritter; Martin Friedlander; Debora A Nicoll; Joy S Frank; Maria C Jordan; Kenneth P Roos; Robert S Ross; Kenneth D Philipson
Journal:  Circ Res       Date:  2004-08-12       Impact factor: 17.367

3.  Patients with end-stage congestive heart failure treated with beta-adrenergic receptor antagonists have improved ventricular myocyte calcium regulatory protein abundance.

Authors:  H Kubo; K B Margulies; V Piacentino; J P Gaughan; S R Houser
Journal:  Circulation       Date:  2001-08-28       Impact factor: 29.690

4.  Abnormal Ca2+ release, but normal ryanodine receptors, in canine and human heart failure.

Authors:  Ming Tao Jiang; Andrew J Lokuta; Emily F Farrell; Matthew R Wolff; Robert A Haworth; Héctor H Valdivia
Journal:  Circ Res       Date:  2002-11-29       Impact factor: 17.367

5.  Protein kinase A phosphorylation of the ryanodine receptor does not affect calcium sparks in mouse ventricular myocytes.

Authors:  Yanxia Li; Evangelia G Kranias; Gregory A Mignery; Donald M Bers
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

6.  Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression.

Authors:  Xander H T Wehrens; Stephan E Lehnart; Steven Reiken; John A Vest; Anetta Wronska; Andrew R Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-06       Impact factor: 11.205

Review 7.  Abnormalities of calcium cycling in the hypertrophied and failing heart.

Authors:  S R Houser; V Piacentino; J Weisser
Journal:  J Mol Cell Cardiol       Date:  2000-09       Impact factor: 5.000

8.  Adverse consequences of high sympathetic nervous activity in the failing human heart.

Authors:  D M Kaye; J Lefkovits; G L Jennings; P Bergin; A Broughton; M D Esler
Journal:  J Am Coll Cardiol       Date:  1995-11-01       Impact factor: 24.094

9.  Adrenergic regulation of cardiac contractility does not involve phosphorylation of the cardiac ryanodine receptor at serine 2808.

Authors:  Scott M MacDonnell; Gerardo García-Rivas; Joseph A Scherman; Hajime Kubo; Xiongwen Chen; Héctor Valdivia; Steven R Houser
Journal:  Circ Res       Date:  2008-04-03       Impact factor: 17.367

10.  Transgenic overexpression of the sarcoplasmic reticulum Ca2+ATPase improves reticular Ca2+ handling in normal and diabetic rat hearts.

Authors:  Roland Vetter; Uwe Rehfeld; Christoph Reissfelder; Wolfgang Weiss; Kay-Dietrich Wagner; Joachim Günther; Annette Hammes; Carsten Tschöpe; Wolfgang Dillmann; Martin Paul
Journal:  FASEB J       Date:  2002-08-21       Impact factor: 5.191

View more
  39 in total

Review 1.  Mechanisms of altered Ca²⁺ handling in heart failure.

Authors:  Min Luo; Mark E Anderson
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

2.  Ryanodine receptor phosphorylation and heart failure: phasing out S2808 and "criminalizing" S2814.

Authors:  Héctor H Valdivia
Journal:  Circ Res       Date:  2012-05-25       Impact factor: 17.367

3.  Ablation of the cardiac ryanodine receptor phospho-site Ser2808 does not alter the adrenergic response or the progression to heart failure in mice. Elimination of the genetic background as critical variable.

Authors:  Francisco J Alvarado; Xi Chen; Héctor H Valdivia
Journal:  J Mol Cell Cardiol       Date:  2017-01-06       Impact factor: 5.000

4.  A compartmentalized mathematical model of the β1-adrenergic signaling system in mouse ventricular myocytes.

Authors:  Vladimir E Bondarenko
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

Review 5.  Abnormal Ca(2+) cycling in failing ventricular myocytes: role of NOS1-mediated nitroso-redox balance.

Authors:  Mark T Ziolo; Steven R Houser
Journal:  Antioxid Redox Signal       Date:  2014-08-07       Impact factor: 8.401

6.  Genetic deletion of Rnd3/RhoE results in mouse heart calcium leakage through upregulation of protein kinase A signaling.

Authors:  Xiangsheng Yang; Tiannan Wang; Xi Lin; Xiaojing Yue; Qiongling Wang; Guoliang Wang; Qin Fu; Xun Ai; David Y Chiang; Christina Y Miyake; Xander H T Wehrens; Jiang Chang
Journal:  Circ Res       Date:  2014-10-27       Impact factor: 17.367

7.  Genetic ablation of ryanodine receptor 2 phosphorylation at Ser-2808 aggravates Ca(2+)-dependent cardiomyopathy by exacerbating diastolic Ca2+ release.

Authors:  Bin Liu; Hsiang-Ting Ho; Florencia Velez-Cortes; Qing Lou; Carmen R Valdivia; Bjorn C Knollmann; Hector H Valdivia; Sandor Gyorke
Journal:  J Physiol       Date:  2014-01-20       Impact factor: 5.182

8.  Integrins protect cardiomyocytes from ischemia/reperfusion injury.

Authors:  Hideshi Okada; N Chin Lai; Yoshitaka Kawaraguchi; Peter Liao; Jeffrey Copps; Yasuo Sugano; Sunaho Okada-Maeda; Indroneal Banerjee; Jan M Schilling; Alexandre R Gingras; Elizabeth K Asfaw; Jorge Suarez; Seok-Min Kang; Guy A Perkins; Carol G Au; Sharon Israeli-Rosenberg; Ana Maria Manso; Zheng Liu; Derek J Milner; Stephen J Kaufman; Hemal H Patel; David M Roth; H Kirk Hammond; Susan S Taylor; Wolfgang H Dillmann; Joshua I Goldhaber; Robert S Ross
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

9.  Imatinib activates pathological hypertrophy by altering myocyte calcium regulation.

Authors:  Larry A Barr; Catherine A Makarewich; Remus M Berretta; Hui Gao; Constantine D Troupes; Felix Woitek; Fabio Recchia; Hajime Kubo; Thomas Force; Steven R Houser
Journal:  Clin Transl Sci       Date:  2014-06-16       Impact factor: 4.689

Review 10.  Understanding How Phosphorylation and Redox Modifications Regulate Cardiac Ryanodine Receptor Type 2 Activity to Produce an Arrhythmogenic Phenotype in Advanced Heart Failure.

Authors:  Alexander Dashwood; Elizabeth Cheesman; Nicole Beard; Haris Haqqani; Yee Weng Wong; Peter Molenaar
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.